LAUPHEIM, Germany--(BUSINESS WIRE)--Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto (46) as Chief ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results